Device Trial Radar · NCT02562677
TNS for Treating Major Depressive Disorder in the Elderly
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 2015
Primary completion
Dec 2015
Study completion Feb 2016
Sponsor
- Lead sponsor
- Santa Casa Medical SchoolAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 29, 2015
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 65 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase II, open-label clinical trial. This clinical trial has as primary objective to evaluate changes in EEG of a Trigeminal Nerve Stimulation (TNS) treatment protocol for elderly patients with moderate / severe depressive episode.
Conditions
- Major Depressive Disorder
- Elderly
Interventions
Transcutaneous Trigeminal Nerve StimulationDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hamilton Depressive Rating Scale version 17 items (HDRS-17)Time frame: Change from baseline in depressive symptoms at 2 weeks ]
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.